Acetaminophen May Not Be the Best Choice for Arthritis Pain

This article originally appeared here.
Share this content:
Acetaminophen May Not Be the Best Choice for Arthritis Pain
Acetaminophen May Not Be the Best Choice for Arthritis Pain

FRIDAY, March 18, 2016 (HealthDay News) -- Acetaminophen isn't an effective choice for osteoarthritis pain in the hip or knee, or for improving joint function, according to a report published online March 17 in The Lancet.

The current research included information from 74 trials published between 1980 and 2015. These trials included 58,556 patients. The studies compared how well various doses of acetaminophen and seven different nonsteroidal anti-inflammatory drugs (NSAIDs) relieved arthritis pain.

The researchers found that acetaminophen was slightly better than placebo. But they added that the improvements in pain and physical function did not reach the minimum clinically important difference (effect size of −0.17 versus clinically important difference of −0.37). The team determined that diclofenac at a dose of 150 mg/day was the most effective treatment for pain and disability.

Tylenol manufacturer McNeil Consumer Healthcare took issue with the new study. "We disagree with the authors' interpretation of this meta-analysis and believe acetaminophen remains an important pain relief option for millions of consumers, particularly those with certain conditions for which NSAIDs may not be appropriate -- including cardiovascular disease, gastrointestinal bleeding, and renal disease," the company said in a prepared statement.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »